retatrutide type 2 diabetes phase 2 trial hba1c Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide in Obesity and Diabetes
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28




















![Sink Below (Red) [WTR215-C] (Welcome to Rathe) Alpha Print Normal BW63](https://cdn.shopify.com/s/files/1/0378/1125/7476/products/76b31e94-a531-4b57-9a86-67e300a07a47_be4d1e00-ed79-4434-bb3f-b2a3d3b4b598.png?v=1664557863)